Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53136

言語	英語
著者	Chattopadhyay Subhayan a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Zheng Guoqiao a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Sud Amit Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Yu Hongyao a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany b Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Sundquist Kristina d Center for Primary Health Care Research, Lund University, Malmö, Sweden e Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA f Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Sundquist Jan a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germanye Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA f Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Foersti Asta a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany d Center for Primary Health Care Research, Lund University, Malmö, Sweden Hemminki Akseli g Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Finland h Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland Houlston Richard c Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK i Division of Molecular Pathology, The Institute of Cancer Research, London, UK Hemminki Kari a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany d Center for Primary Health Care Research, Lund University, Malmö, Sweden
掲載誌名	LANCET HAEMATOLOGY
巻	5
号	8
開始ページ	E368
終了ページ	E377
ISSN	2352-3026
発行日	2018-08
DOI	10.1016/S2352-3026(18)30108-X
PubMed ID	30075833
出版者	ELSEVIER SCI LTD
資料タイプ	学術雑誌論文
部局	医学部
備考	Deutsche Krebshilfe, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, Swedish Research Council, ALF from Region Skane, and Bloodwise.